Association for
Multiple Endocrine
Neoplasia Disorders
Home
Patients
Disease Information
MEN 1
MEN 2a
MEN 2B / MEN3
FMTC
PPGL Syndromes
PHAEO/PARA
FIPA
ACC
MTC
Patient Stories
All Resources
Support Services
AMEND Counselling Service
Introduction to Mindfulness
10 @ 10 Mindful Mondays
Mindfulness and MEN
Mindfulness FAQs
More Information About Mindfulness
Events
National Events
Peer Support Meetings
Social Media
Videos
AMEND Webcasts (New!)
Physical Fitness
MEN Passport
Centres of expertise
Finance & insurance advice
Kids (5-12 Years)
Our Work
Research Opportunities
Feedback
USA
Join
Useful Links
Young Adults (13-25 Years)
Healthcare
Professionals
AMEND Medical
Advisors
AMEND Research
Fund
Order resources
Other Ways We Can Help
Join
Fundraisers &
Supporters
Acknowledgements
Fundraising Opportunities
Donate
Legacy Information
Internships
Volunteer
News
AMEND Shop
Contact Us
Home
Patients
Disease Information
MEN 1
MEN 2a
MEN 2B / MEN3
FMTC
PPGL Syndromes
PHAEO/PARA
FIPA
ACC
MTC
Patient Stories
All Resources
Support Services
AMEND Counselling Service
Introduction to Mindfulness
10 @ 10 Mindful Mondays
Mindfulness and MEN
Mindfulness FAQs
More Information About Mindfulness
Events
National Events
Peer Support Meetings
Social Media
Videos
AMEND Webcasts (New!)
Physical Fitness
MEN Passport
Centres of expertise
Finance & insurance advice
Kids (5-12 Years)
Our Work
Research Opportunities
Feedback
USA
Join
Useful Links
Young Adults (13-25 Years)
Healthcare
Professionals
AMEND Medical
Advisors
AMEND Research
Fund
Order resources
Other Ways We Can Help
Join
Fundraisers &
Supporters
Acknowledgements
Fundraising Opportunities
Donate
Legacy Information
Internships
Volunteer
News
AMEND Shop
Contact Us
6 Jan 2026
New Phase 3 Clinical Trial for Hyperinsulinism Drug
Return to Latest News
